Home4503 • TYO
add
Astellas Pharma Inc
Nakaraang pagsara
¥1,439.00
Sakop ng araw
¥1,434.00 - ¥1,464.00
Sakop ng taon
¥1,243.50 - ¥1,835.00
Market cap
2.64T JPY
Average na Volume
7.43M
P/E ratio
51.63
Dividend yield
5.08%
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 459.29B | 10.78% |
Gastos sa pagpapatakbo | 328.33B | 16.59% |
Net na kita | 74.90B | 325.06% |
Net profit margin | 16.31 | 303.11% |
Kita sa bawat share | — | — |
EBITDA | 101.78B | -6.11% |
Aktuwal na % ng binabayarang buwis | -23.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 188.37B | -43.88% |
Kabuuang asset | 3.34T | -6.44% |
Kabuuang sagutin | 1.83T | -7.46% |
Kabuuang equity | 1.51T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 1.70 | — |
Return on assets | 3.98% | — |
Return on capital | 5.69% | — |
Cash Flow
Net change in cash
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 74.90B | 325.06% |
Cash mula sa mga operasyon | 101.08B | 40.42% |
Cash mula sa pag-invest | -2.96B | 86.62% |
Cash mula sa financing | -90.81B | -393.61% |
Net change in cash | 8.51B | -89.59% |
Malayang cash flow | 50.68B | -8.05% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
14,754
